Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea

Conditions: Moderate-to-severe Plaque Psoriasis Interventions: Drug: Deucravacitinib Sponsors: Bristol-Myers Squibb Not yet recruiting

Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials